Started: 10/2018
Study Name: Protocol Title: A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of XXX and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)
Indication: Pneumococcal
Principal Investigators: Luke Anschutz, Paul Bernhardson, Brad Brabec, Steve Russell